Skip to content
lifestyle.buyersdesire.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Humacyte, Inc
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
March 19, 2026
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
March 17, 2026
Humacyte To Participate in Upcoming Investor Conferences
March 12, 2026
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
March 11, 2026
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
March 9, 2026
←
Previous Page
1
2
3